Investigating the Association Between Central Sensitization and Breathing Pattern Disorders
Launched by SAHMYOOK UNIVERSITY · Jun 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how breathing patterns may be related to a condition called central sensitization, which can lead to chronic pain. The researchers want to understand if problems with how people breathe could affect their pain levels. This is important because breathing issues can contribute to both physical and mental health problems. By studying adults, the trial hopes to find connections between breathing patterns and pain to help improve pain management strategies.
To participate in this study, you need to be at least 18 years old and have a certain score on a specific questionnaire about central sensitization. However, if you have serious heart or lung conditions, very high blood pressure, or cognitive difficulties, you won't be eligible. If you join the trial, you will help researchers assess your breathing and pain, which could lead to better treatments for others in the future. Keep in mind that the study is not yet recruiting participants, so there will be more information available soon!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 and above.
- • Individuals scoring 40 or above on the Central Sensitization Inventory for Koreans (CSI-K).
- • Individuals who consent to the use and publication of their personal information and wish to participate in assessment measurements.
- Exclusion Criteria:
- • Individuals with pulmonary, cardiac, or respiratory diseases.
- • Individuals with severe hypertension, defined as systolic blood pressure ≥ 160 mmHg or diastolic blood pressure ≥ 100 mmHg.
- • Individuals with cognitive impairments.
- • Individuals who express a desire to withdraw from the study during its duration.
About Sahmyook University
Sahmyook University is a distinguished academic institution based in South Korea, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in health sciences and innovative research methodologies to facilitate high-quality clinical studies. Sahmyook University aims to contribute to the development of effective therapeutic interventions and enhance patient care through rigorous clinical trials that adhere to ethical standards and regulatory guidelines. By fostering collaboration among researchers, healthcare professionals, and industry partners, the university is dedicated to translating scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gwangju, , Korea, Republic Of
Patients applied
Trial Officials
Hyunjoong Kim, PhD
Principal Investigator
Gwangju Health University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported